131 related articles for article (PubMed ID: 1261590)
1. Comparative effects of four migraine prophylactic drugs on an isolated extracranial artery.
Fozard JR
Eur J Pharmacol; 1976 Mar; 36(1):127-139. PubMed ID: 1261590
[TBL] [Abstract][Full Text] [Related]
2. Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta.
Apperley E; Humphrey PP; Levy GP
Br J Pharmacol; 1976 Oct; 58(2):211-21. PubMed ID: 184872
[TBL] [Abstract][Full Text] [Related]
3. Effects of methysergide, pizotifen and ergotamine in the monkey cranial circulation.
Mylecharane EJ; Spira PJ; Misbach J; Duckworth JW; Lance JW
Eur J Pharmacol; 1978 Mar; 48(1):1-9. PubMed ID: 416960
[TBL] [Abstract][Full Text] [Related]
4. The effects of antimigraine drugs on the vascular responses by-5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: possible pharmacological implications to their antimigraine action.
Saxena PR
Headache; 1972 Jul; 12(2):44-54. PubMed ID: 5056178
[No Abstract] [Full Text] [Related]
5. Comparative effects of noradrenaline and serotonin in a central and a peripheral artery in vitro.
Tayo FM
Afr J Med Med Sci; 1983; 12(3-4):139-43. PubMed ID: 6326547
[TBL] [Abstract][Full Text] [Related]
6. Blockade by phentolamine of the potentiation of histamine-induced vasoconstriction caused by serotonin and methysergide in the rabbit ear artery.
Carroll PR; Morgans D; Glover WE
Clin Exp Pharmacol Physiol; 1977; 4(1):43-8. PubMed ID: 884902
[TBL] [Abstract][Full Text] [Related]
7. The animal pharmacology of drugs used in the treatment of migraine.
Fozard JR
J Pharm Pharmacol; 1975 May; 27(5):297-321. PubMed ID: 239131
[No Abstract] [Full Text] [Related]
8. Antimigraine drug interactions with 5-hydroxytryptamine1A receptors.
Hiner BC; Roth HL; Peroutka SJ
Ann Neurol; 1986 May; 19(5):511-3. PubMed ID: 2940961
[TBL] [Abstract][Full Text] [Related]
9. Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine.
Hardebo JE; Edvinsson L; Owman C; Svendgaard NA
Neurology; 1978 Jan; 28(1):64-70. PubMed ID: 563539
[TBL] [Abstract][Full Text] [Related]
10. Centrally mediated antihypertensive and bradycardic effects of methysergide in spontaneously hypertensive rats.
Antonaccio MJ; Coté D
Eur J Pharmacol; 1976 Apr; 36(2):451-4. PubMed ID: 1278233
[TBL] [Abstract][Full Text] [Related]
11. The responses of the human temporal and rabbit ear artery to 5-hydroxytryptamine and some of its antagonists.
Carroll PR; Ebeling PW; Glover WE
Aust J Exp Biol Med Sci; 1974 Oct; 52(5):813-23. PubMed ID: 4155619
[No Abstract] [Full Text] [Related]
12. Evaluation of drugs applicable to treatment of migraine in the cranial circulation of the monkey.
Lance JW; Spira PJ; Mylecharane EJ; Lord GD; Duckworth JW
Res Clin Stud Headache; 1978; 6():13-8. PubMed ID: 103151
[No Abstract] [Full Text] [Related]
13. Responses of isolated canine intermediate auricular arteries to 5-hydroxytryptamine and methysergide.
Ito T; Chiba S
Eur J Pharmacol; 1984 Sep; 104(1-2):105-9. PubMed ID: 6499909
[TBL] [Abstract][Full Text] [Related]
14. A pre-junctional action of 5-hydroxytryptamine and methysergide on noradrenergic nerves in dog isolated saphenous vein.
Watts AD; Feniuk W; Humphrey PP
J Pharm Pharmacol; 1981 Aug; 33(8):515-20. PubMed ID: 6115926
[TBL] [Abstract][Full Text] [Related]
15. [Serotonin agonists and antagonists in migraine].
Ollat H
Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874
[TBL] [Abstract][Full Text] [Related]
16. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
Villalón CM; De Vries P; Rabelo G; Centurión D; Sánchez-López A; Saxena P
Br J Pharmacol; 1999 Feb; 126(3):585-94. PubMed ID: 10188968
[TBL] [Abstract][Full Text] [Related]
17. Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature.
Apperley E; Feniuk W; Humphrey PP; Levy GP
Br J Pharmacol; 1980 Feb; 68(2):215-24. PubMed ID: 7357206
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of action of drugs currently used in the prevention of migraine].
Fanchamps A
Minerva Med; 1976 Jun; 67(28):1858-60. PubMed ID: 59325
[TBL] [Abstract][Full Text] [Related]
19. Evidence that serotonin receptors mediate the cutaneous vasoconstriction produced by 5-hydroxytryptamine in canine forelimbs.
Dobbins DE; Adamski SW; Lokhandwala MF; Grega GJ
Circ Res; 1983 Oct; 53(4):473-81. PubMed ID: 6627607
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a presynaptic inhibitory action of 5-hydroxytryptamine on sympathetic neurotransmission to the myocardium.
Martinez AA; Lokhandwala MF
Eur J Pharmacol; 1980 May; 63(4):303-11. PubMed ID: 6248349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
